ARCHIVES 2010 OF LEPROSY MAILING LIST (LML)
(Organised by Date)

Check the LML Blog                    LML Archives Homepage

(This page last Updated on 19/01/2011)

December 2010

• 31.12.10 Leprosy in the teaching curricula, Ryan T.

• 31.12.10 Present fear is relapse of leprosy, Porichha D.

• 31.12.10 Nippon Foundation stops funding WHO initiative on surveillance of drug resistance in leprosy, Rao N. P.

• 29.12.10 Eponyms in leprology, Al Aboud K.

• 28.12.10 A new book on Vitiligo, Salafia A.

• 18.12.10 Loss of clinical expertise in leprosy in Africa , Noto S.

• 18.12.10 Priorities for future of leprosy control: communication by Professor T Ryan, Das P. K.

• 18.12.10 Priorities for future of leprosy control, Samy A. A.

• 16.12.10 Priorities for leprosy control, Ryan T.

• 11.12.10 Priorities for future of leprosy control, Revankar C. R.

• 11.12.10 The letter of Dr Pannikar, Parichha D.

• 09.12.10 The letter of Dr. Pannikar, Salafia A.

• 09.12.10 The Downfall of Leprosy Expertise (to pauperism), Both P.

• 08.12.10 Priorities for future of leprosy control, Gajete F.

• 08.12.10 Priorities for future in leprosy control, Garbino J. A.

• 08.12.10 Current donor (Nippon Foundation) stops funding WHO initiative on surveillance of drug resistance in leprosy, Lechat M. F.

• 08.12.10 Current donor (Nippon Foundation) stops funding WHO initiative on surveillance of drug resistance in leprosy, Das P. K.

• 05.12.10 Priorities for future of leprosy control, Pannikar V.

• 04.12.10 BIKASH Nepal - International training announcement 2011, Gurug G.

November 2010

• 30.11.10 Indian Dermatology Online Journal, Verma S. B.

• 18.11.10 Infoleps choice of new (e-)publications on leprosy, Erlings J.

• 06.11.10 Perforation of the palate in leprosy, Noto S.

• 06.11.10 Case presentation (Perforation of the palate in leprosy), Tauvenet J. W.

• 05.11.10 Case presentation, Tamang K.

• 05.11.10 Rifampicin, ofloxacin and minocycline (ROM) in leprosy, Soutar D.

• 03.11.10 Rifampicin, ofloxacin and minocycline (ROM) in leprosy , Frankel R. I.

• 03.11.10 Rifampicine, ofloxacin and minocycline (ROM) in leprosy, Kar H. K.

• 02.11.10 Single dose treatment for single lesion leprosy, Ahmad L.

• 02.11.10 Looking for Doctor with experience in leprosy in (or near) Vancouver , British Colombia, Canada, Lagault M.

October 2010

• 30.10.10 Leprosy in Wikipedia, Al Aboud K. M.

• 09.10.10 Pharmacogenetic studies of response to treatment erythema nodosum leprosum, Faccini L. S.

• 09.10.10 Combined clofazimine and dapsone resistant leprosy: a case report, Kar H. K.

• 09.10.10 The concept of “elimination” is confusing, indeed, Modi N.

• 07.10.10 Clofazimine, Kawuma H. J.

• 05.10.10 I would like to back up Prof Ryan’s request, Warren G.

• 05.10.10 Research groups discussing on future priority researches, Gajete F. C.

• 02.10.10 Has clofazimine resistance seen to develop in a patient?, Kawuma H. J.

September 2010

• 29.09.10 Has clofazimine resistance seen to develop in a patient?, Warren G.

• 28.09.10 Prof. Terence Ryan's concern, Ganapati R.

• 28.09.10 Clofazimine and erythema nodosum leprosum (ENL or type 2) reaction, Kar H. K.

• 25.09.10 Reference required, Ryan T.

• 25.09.10 Clofazimine in high dosage used for the treatment of late ENL reaction in leprosy: could it mask a relapse?, de Oliviera M. L. W.

• 22.09.10 Clofazimine in ENL, Theuvenet W.

• 22.09.10 Indeterminate leprosy, Palande D. D.

• 17.09.10 Indeterminate leprosy, Shumin C.

• 12.09.10 About the many aspects of the proper treatment of ENL, Pongtiku A.

• 10.09.10 About the many aspects of the proper treatment of ENL, Warren G.

• 08.09.10 Pieter Schreuder joins the LML staff, Noto S.

• 04.09.10 4^th CAN International Conference on Community-Based Rehabilitation. 26^th – 29^th October, 2010, Abuja , Nigeria , Udo S.O.

• 03.09.10 Prednisolone does not reduce the effectiveness of rifampicin, van Brakel W.

• 03.09.10 Clofazimine in recurrent type 2 (ENL) leprosy reaction, Napit I.

• 02.09.10 Clofazimine in recurrent type 2 (ENL) leprosy reaction, Schreuder P. A. M.

• 02.09.10 Clofazimine in recurrent type 2 (ENL) leprosy reaction, Naafs B.

• 02.09.10 Clofazimine in recurrent or chronic or steroid dependent type 2 leprosy reaction, Kar H. K.

• 02.09.10 Prednisolone changes the rifampicin effectiveness?, Warren G.

• 02.09.10 Clofazimine in ENL reaction, Gajete F.

August 2010

• 29.08.10 Cordial invitation from the Indian Association of Community Ophthalmology, Samanta S. K.

• 29.08.10 Can drug used in leprosy (Clofazimine, Dapsone, Rifampicin and Prednisolone) cause hyponatraemia?, Naafs B.

• 29.08.10 Can drug used in leprosy (Clofazimine, Dapsone, Rifampicin and Prednisolone) cause hyponatraemia?, Duncan L.

• 29.08.10 Clofazimine in ENL reaction, Romero A.S.

• 27.08.10 Digital photos needed of people who are reading, Erlings J.

• 27.08.10 Weekly Epidemiological Record, issue 35, 2010, 85, p 337–348, Erlings J.

• 24.08.10 BIKASH Nepal , training announcement 2011, Gurung G.

• 24.08.10 Leprosy-related courses being held at ALERT in the coming months, Kebede E.

• 23.08.10 Can drug used in leprosy (Clofazimine, Dapsone, Rifampicin and Prednisolone) cause hyponatraemia?, Adamou I.

• 22.08.10 Community Based Rehabilitation course, Addis Ababa , Ethiopia , 15 – 26 November 2010, Cornielje H.

May 2010

• 16.05.10 Temporary closure of Leprosy Mailing List, Noto S.

• 16.05.10 Reactions after stopping Multi-drug Therapy, Ganapati R.

• 16.05.10 Mid Term Conference of Indian Association of Leprologists, 2nd & 3rd October, 2010, Guwahati Assam , India, Swapan K. S.

• 16.05.10 “Diagnosis of leprosy” also available on line in the “Portal da Hanseniase”, Rodrigues Carlos A.F.

• 11.05.10 Loose clofazimine availability in The Philippines and in Gabon, Gajete F.C., Mondjo A.

• 10.05.10 Clofazimine for ENL in pregnancy, Duncan E.

• 10.05.10 Feeding 25 mg dose of clofazimine daily to a 2 year baby, Kar. H. K.

• 10.05.10 Multi-drug therapy (MDT) dosages in Ethiopian guidelines, Kebede E.

• 10.05.10 Clofazimine availability and distribution, Post E.

• 09.05.10 PHARE BELGIUM is planning to produce loose clofazimine very soon, Declercq E.

• 09.05.10 MDT in a 2 year old child, Kawahita I.

• 09.05.10 MDT in a 2 year old child, Naafs B.

• 09.05.10 Small child MDT - please advise, Lambert S.

• 07.05.10 Diagnosis of leprosy - Part III. Text and slides, Noto S., Schreuder P.A.M.

• 06.05.10 Diagnosis of leprosy - Part II. Cardinal signs, slides 3, Noto S., Schreuder P.A.M.

• 05.05.10 Diagnosis of leprosy - Part II, Noto S., Schreuder P.A.M.

• 03.05.10 Clofazimine (Hansaprin) commercially available in India, Dhakal K. P.

• 03.05.10 Loose clofazimine available for the treatment of erythema nodosum leprosum (ENL) reaction via WHO, Loedige B.

• 03.05.10 Loose clofazimine available for the treatment of erythema nodosum leprosum (ENL) reaction via WHO, Schmotzer C.

• 03.05.10 Can loose clofazimine be made available for the treatment of erythema nodosum leprosum (ENL) reaction?, Koning P.D.

April 2010

• 30.04.10 Diagnosis of leprosy - Part I, Noto S. Schreuder P.A.M.

• 29.04.10 Diagnosis of leprosy, Deepak S.

• 18.04.10 Disability and Development (D&D) course, Cornielje H.

March 2010

• 28.03.10 Indeterminate (I) leprosy, Warren G.

• 05.03.10 Tourniquet in reconstructive surgery, Narayanakumar T. S.

• 01.03.10 Tourniquet use in upper and lower extremity surgery, Salafia A.

• 01.03.10 Use of tourniquet in upper and lower extremity surgery, Wilton J. P.

February 2010

• 27.02.10 Comments on “tourniquet/strangulation” application and time in reconstructive surgery in leprosy, Ahmed L.

• 22.02.10 Axillary blocks. Better to be sure than sorry!, Warren G.

• 20.02.10 Teledermatology for leprosy and global dermatology, Massone C.

• 13.02.10 Summer School on Disability & Development, Jakarta , Indonesia, Cornielje H.

• 13.02.10 Alternative antibiotic regimens in leprosy - correction, Rea T. H.

• 11.02.10 Axillary block, Theuvenet W.

• 10.02.10 Lamprene (clofazimine), Shreuder P. A.

• 10.02.10 Alternative antibiotic regimens in leprosy, Rea T. H.

• 10.02.10 Alternative regimens for multi-drug therapy (MDT) in leprosy, Naafs B.

• 10.02.10 New multi authored text book of Leprosy, Rao P. N.

• 07.02.10 Alternative Antibiotic Regimens for Leprosy, Ganapati R.

• 07.02.10 Relapse and reaction after patients have been released from treatment (RFT), Ishii N.

• 07.02.10 Clarithromycin as alternative drug for DDS resistant/DDS hypersensitive patients, Gajete F.

• 07.02.10 Clofazimine in the Philippines , Gajete F.

• 07.02.10 VIIIth cranial nerve toxicity caused by minocycline, Frankel R. I.

• 03.02.10 Web links to key WHO Global Leprosy documents, Soutar D.

• 02.02.10 Leprosy patients developing erythema nodosum leprosum (ENL) reactions after stopping multi-drug therapy (MDT), Van Brakel W. H.

• 02.02.10 Alternative antibiotic regimens for leprosy, Van Brakel W. H.

• 02.02.10 Alternative antileprosy regimens, Modi N.

• 01.02.10 Axillary block anaesthesia, Ahmad L.

• 01.02.10 In leprosy axillary and cervical nerve blocks are not recommended, Warren G.

January 2010

• 31.01.10 Medical-legal complications regarding clofazimine in the USA, Scollard D. M.

• 31.01.10 Advert for the position of Chief Executive of LEPRA Health in Action, Jefford Y.

• 28.01.10 Might further delay after releasing from treatment (RFT) or after the most recent nerve function loss or nerve tenderness have lessened the neuritis risk?, Watson J.

• 28.01.10 Possible neuropraxia due to improper/too long application of tourniquet, Joshua J.

• 28.01.10 Medical-legal complications regarding clofazimine in the USA, Ryan T.

• 28.01.10 Nerve function loss after reconstructive surgery, Palande D. D.

• 28.01.10 Possible neuropraxia due to improper/too long application of tourniquet, Wilton J. P.

• 27.01.10 Erythema nodosum leprosum (ENL) reaction after completion of the 12-month multi-drug therapy (MDT) regimen, Naafs B.

• 27.01.10 Possible neuropraxia due to improper/too long application of tourniquet, Brandsma W.

• 27.01.10 Alternative antibiotic regimens for leprosy, Gilead L.

• 27.01.10 Alternative regimens for multi-drug therapy (MDT) in leprosy, Lockwood D.

• 25.01.10 Information about Monitoring and Evaluation Courses Ogbeiwi O. J.

• 25.10.10 Statement of the ILEP President for the World Leprosy Day 2010, Soutar D.

• 25.01.10 Alternative antibiotic regimens in leprosy, Scollard D.

• 24.01.10 Advertisement for the position of Director of the Armauer Hansen Research Institute, Frommel D.

• 23.01.10 Nerve function loss after reconstructive surgery, Piefer A.

• 23.01.10 Erythema nodosum leprosum (ENL) reaction after completion of the 12-month regimen, Das P. K.

• 21.01.10 Information regarding Programme Evaluation course, Hadi S.K.A.

• 21.01.10 Alternative antibiotic regimens for leprosy, Brakel W.H.v.

• 19.01.10 Alternative antibiotic regimens for leprosy?, Glead L.

• 18.01.10 Request of surgeon experienced in reconstructive surgery in Europe, Warren G.

LML Archives Homepage